Company Active LTD

Company profile

Oxford Heartbeat Ltd

Home - Oxford Heartbeat

We bring greater accuracy and safety to high-risk surgical procedures. Our CE marked software PreSize Neurovascular improves the treatment of brain aneurysms.

CRN
09685053
Founded
2015
Age
10

Overview

Legal name
OXFORD HEARTBEAT LTD
Region
Unknown
Registered address
85 GREAT PORTLAND STREET
FIRST FLOOR
LONDON
ENGLAND
W1W 7LT
Insolvency history
No

Latest accounts

Financial period: 1 Aug 2023 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
14

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

27 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

13 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

14 Jul
2015

Incorporated

Inception

Company registered at Companies House

Public funding

12 awards
First funded
2015
Funded years
2015, 2017, 2019, 2020, 2021, 2023, 2024
Age at first award
0 years

Projects

2024 Collaborative R&D Lead participant

PreSize Surgery – novel medical device software for precise execution of best surgical scenario for every patient

1 May 2024 to 30 Apr 2025

Awarded
£499,864
Total cost £714,091

We have developed PreSize medical device software: novel clinical decision-support that helps surgeons plan and rehearse implant placements inside blood vessels with realistic simulations right before starting life-saving surgery. Using cutting-edge computational modelling, we use patient imaging and ultra-realistic implant mechanics to accurately predict...

2023 Collaborative R&D Lead participant

PreSize Diagnostic medical device software for increased precision in advance selection of best surgical scenario for every patient at point of diagnosis

1 Jul 2023 to 31 Dec 2024

Awarded
£629,950
Total cost £899,928

We have developed PreSize medical device software: a novel clinical decision-support solution that helps surgeons plan and rehearse implant placements inside brain blood vessels with realistic, real-time simulations right before starting life-saving surgery. Using cutting-edge computational modelling, we make best use of patient imaging and device mechani...

2023 Collaborative R&D Lead participant

PreSize Net medical device software for realistic surgery planning: next-generation scalable technology for selecting the best surgical scenario for every patient

1 Apr 2023 to 31 Mar 2024

Awarded
£499,398
Total cost £713,426

Our goal is to make cardiovascular surgeries more efficient and safe. This project increases the power of our PreSize medical device software - a novel clinical decision-support solution that helps surgeons plan and rehearse implant placements inside blood vessels with realistic surgery simulations. Using cutting-edge computational modelling, we make the ...

2023 Grant for R&D Lead participant

Stepping up the game: scale up and international expansion for British AI medical software

1 Apr 2023 to 31 Mar 2024

Awarded
£50,000
Total cost £50,000

I am a CEO of Oxford Heartbeat (OxHB) - mission-driven medical technology startup. I am also an Enterprise Fellow of The Royal Academy of Engineering, a PhD in Biomedical Engineering from University of Oxford, MSc in Computer Science from Humboldt University of Berlin (minor in Business) and was previously Researcher in AI at Sony in Paris. I was named a ...

2021 Collaborative R&D Lead participant

Adjusting our regulatory framework to fit the COVID world

1 Nov 2021 to 31 Dec 2021

Awarded
£49,600
Total cost £49,600

Our goal is to make cardiovascular surgeries more efficient and safe. This project develops the PreSize platform, a novel clinical decision-support solution that helps clinicians plan and rehearse stent placements inside blood vessels. Using cutting- edge computational modelling, we make the best use of available patient scans and stent device mechanics t...

2021 Feasibility Studies Lead participant

PreSize medical device software that allows pre-operative rehearsals of stenting surgeries to reduce complications

1 Apr 2021 to 31 Mar 2023

Awarded
£1,545,568
Total cost £2,207,954

Our goal is to make cardiovascular surgeries more efficient and safe. This project develops the PreSize platform, a novel clinical decision-support solution that helps clinicians plan and rehearse stent placements inside blood vessels. Using cutting-edge computational modelling, we make the best use of available patient scans and stent device mechanics to...

2020 Feasibility Studies Lead participant

Continuity of BMC-P Project "PreSize Stenting – medical software that allows pre-operative rehearsals of stenting surgeries to reduce complications" and its online adaptation

1 Jun 2020 to 30 Nov 2020

Awarded
£250,000
Total cost £250,000

no public description

2019 Feasibility Studies Lead participant

PreSize Stenting - medical software that allows pre-operative rehearsals of stenting surgeries to reduce complications

1 Apr 2019 to 30 Jun 2021

Awarded
£697,886
Total cost £996,980

"Our goal is to make cardiovascular surgeries more efficient and safe. This project develops the PreSize Stenting Platform, a novel solution that helps clinicians plan and rehearse stent placements inside blood vessels. Using cutting-edge computational modelling, we make the best use of available patient scans and stent device mechanics to accurately pred...

2019 Collaborative R&D Lead participant

Obtaining high accuracy measurements of medical stents from 2D X-ray images

1 Jan 2019 to 31 Mar 2019

Awarded
£29,692
Total cost £29,692

"Oxford Heartbeat (OxHB) is an early-stage start-up developing innovative technology to make cardiovascular surgeries more efficient and effective. We are building software that helps surgeons plan and rehearse minimally invasive stent placements inside blood vessels -- currently the most popular treatment for common cardiovascular disorders. The software...

2019 Study Lead participant

Knowledge repository for surgery preparations

1 Jan 2019 to 31 Mar 2019

Awarded
£28,001
Total cost £40,002

Stenting is a popular treatment for common cardiovascular diseases, such as aneurysms or stenosis, performed in hospitals on a daily basis. Stents are small metallic tubes surgically placed inside diseased blood vessels to provide vascular support or relieve obstructions. Although, stenting is becoming more and more popular due to its minimally-invasive n...

2017 Feasibility Studies Lead participant

Precise Stenting

1 Feb 2017 to 31 Jan 2018

Awarded
£140,000
Total cost £200,000

Our goal is to make cardiovascular surgeries more efficient and safe. We propose to develop technology that helps clinicians to accurately plan and rehearse stent placements inside blood vessels. Using cutting-edge computational modelling, we make maximum use of available patient data and device mechanics to accurately predict the behaviour of devices ins...

2015 GRD Proof of Market Lead participant

Oxford Heartbeat LTD

1 Oct 2015 to 30 Jun 2016

Awarded
£24,999
Total cost £41,700

This project aims to validate the requirements and market potential of a software tool for surgeons to assist their decision making process and enable improvements in quality of care, efficiency and treatment outcomes.

Product types

Collaborative R&D Feasibility Studies Grant for R&D GRD Proof of Market Study